Eye Ointment
Tobra 3 mg/gm Eye Ointment
Generic: Tobramycin
Manufacturer: Alco Pharma Limited
Therapeutic class: Aminoglycoside antibiotic
What is Tobra used for?
Tobra (Eye Ointment) contains Tobramycin 3 mg/gm and is made by Alco Pharma Limited. Therapeutic class: Aminoglycoside antibiotic.
What is Tobra?
Tobra 3 mg/gm eye ointment by Alco Pharma Limited is a medicine containing Tobramycin. In Bangladesh, it is mainly used as an antibiotic preparation for susceptible bacterial eye infections, and in respiratory solution form for selected patients with chronic Pseudomonas aeruginosa lung infection, such as in cystic fibrosis, when prescribed.
Tobramycin works by stopping susceptible bacteria from making essential proteins, which helps kill the bacteria. A key caution is that aminoglycosides can cause allergy and, with significant systemic exposure, may affect hearing, balance, kidneys, or breathing, so it should be used only as directed.
Indications
- Treatment of external bacterial infections of the eye and its adnexa, such as bacterial conjunctivitis, blepharitis, and keratitis, caused by susceptible organisms.
- Inhaled respiratory solution: management of chronic lung infection due to Pseudomonas aeruginosa in appropriate patients with cystic fibrosis, as prescribed by a specialist.
- It is not useful for viral or fungal eye infections unless a bacterial infection is also being treated under medical supervision.
Dosage & Administration
ChamberBD shows dosing only from the approved product label, with its source named, and no label is on file for Tobra 3 mg/gm Eye Ointment. Use the dose your doctor prescribed and the instructions in the pack leaflet.
Side Effects
- Eye preparations: temporary burning, stinging, irritation, itching, redness, eyelid swelling, tearing, or blurred vision after application.
- Eye preparations: allergic reaction or worsening eye inflammation; seek medical help if severe pain, swelling, rash, or vision changes occur.
- Inhaled solution: cough, throat irritation, voice change, wheezing, shortness of breath, chest tightness, or altered taste.
- Serious but less common risks, especially with significant systemic exposure or combined aminoglycoside therapy: hearing loss, ringing in the ears, dizziness or balance problems, kidney problems, and neuromuscular weakness or breathing difficulty.
Precautions & Warnings
Tell the doctor if there is allergy to tobramycin or other aminoglycosides, kidney disease, hearing or balance problems, myasthenia gravis, Parkinson’s disease, breathing problems, or if other antibiotic, kidney-affecting, or hearing-affecting medicines are being used. Avoid touching the eye dropper or ointment tip to the eye or any surface, and do not wear contact lenses during an active eye infection unless advised. Inhaled solution should be used with the recommended nebuliser system and stopped only if the doctor advises. Use under a registered doctor's or pharmacist's guidance.
Drug Interactions
- Other aminoglycosides or medicines that may damage the kidneys or hearing can increase toxicity risk, especially if tobramycin is absorbed systemically.
- Loop diuretics such as furosemide or ethacrynic acid may increase the risk of hearing-related toxicity when combined with aminoglycosides.
- Neuromuscular blocking medicines, anaesthetics, or conditions causing muscle weakness may increase the risk of breathing difficulty.
- If using more than one eye medicine, separate applications by several minutes; apply eye ointment last unless advised otherwise.
- No important food interaction is expected with eye or inhaled forms.
Contraindications
- Known hypersensitivity to tobramycin.
- Known hypersensitivity to other aminoglycoside antibiotics or to any component of the product.
- Use in non-bacterial eye conditions without medical supervision is inappropriate and may delay correct treatment.
Pregnancy & Lactation
During pregnancy or breastfeeding, tobramycin should be used only when the expected benefit justifies the potential risk and after medical advice. Eye preparations usually have low systemic absorption, and inhaled preparations have lower systemic exposure than injections, but aminoglycosides as a class can be associated with fetal or infant safety concerns when systemic exposure is significant. Breastfeeding mothers should seek advice and monitor the baby for unusual symptoms such as diarrhoea, rash, or thrush.
Storage Conditions
Store as printed on the pack and keep out of the reach of children.